van der Poel H - Search Results

1

Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting.

Aluwini SS, Mehra N, Lolkema MP, Oprea-Lager DE, Yakar D, Stoevelaar H, van der Poel H; Dutch Oligometastatic Prostate Cancer Working Group; Busstra M, de Jong IJ, de Reijke T, de Vries K, Heijmink S, Jenster G, Klaver S, Kneppers J, Lavalaye J, Leyten G, Moonen L, Nagaraj J, Noordzij W, Osanto S, Oving I, Schaake E, Scheenen T, Schoots I, Sedelaar M, Somford D, van den Berkmortel F, van der Hulle T, van der Voort van Zyp J, van Leeuwen P, van Moorselaar J, van Oort I, Vogel W, Westgeest H. Aluwini SS, et al. Among authors: van moorselaar j, van oort i, van der poel h, van den berkmortel f, van der voort van zyp j, van der hulle t, van leeuwen p. Eur Urol Oncol. 2020 Apr;3(2):231-238. doi: 10.1016/j.euo.2019.07.010. Epub 2019 Aug 8. Eur Urol Oncol. 2020. PMID: 31401014

2

Quantitative light microscopy in urological oncology.

van der Poel HG, Schaafsma HE, Vooijs GP, Debruyne FM, Schalken JA. van der Poel HG, et al. J Urol. 1992 Jul;148(1):1-13. doi: 10.1016/s0022-5347(17)36494-7. J Urol. 1992. PMID: 1613843 Review. No abstract available.

3

Intratumoral nuclear morphologic heterogeneity in prostate cancer.

van der Poel HG, Oosterhof GO, Schaafsma HE, Debruyne FM, Schalken JA. van der Poel HG, et al. Urology. 1997 Apr;49(4):652-7. doi: 10.1016/s0090-4295(96)00557-2. Urology. 1997. PMID: 9111646 Free article.

4

Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer.

Van der Poel HG, Van Balken MR, Schamhart DH, Peelen P, de Reijke T, Debruyne FM, Schalken JA, Witjes JA. Van der Poel HG, et al. Among authors: van balken mr. Urology. 1998 Jan;51(1):44-50. doi: 10.1016/s0090-4295(97)00496-2. Urology. 1998. PMID: 9457287

5

The Bard BTA test: its mode of action, sensitivity and specificity, compared to cytology of voided urine, in the diagnosis of superficial bladder cancer.

Schamhart DH, de Reijke TM, van der Poel HG, Witjes JA, de Boer EC, Kurth K, Schalken JA. Schamhart DH, et al. Among authors: van der poel hg. Eur Urol. 1998 Aug;34(2):99-106. doi: 10.1159/000019692. Eur Urol. 1998. PMID: 9693243 Clinical Trial.

6

Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer.

Sedelaar JP, van Leenders GJ, Hulsbergen-van de Kaa CA, van der Poel HG, van der Laak JA, Debruyne FM, Wijkstra H, de la Rosette JJ. Sedelaar JP, et al. Among authors: van leenders gj, van der laak ja, van der poel hg. Eur Urol. 2001 Sep;40(3):285-93. doi: 10.1159/000049788. Eur Urol. 2001. PMID: 11684844

7

Smart drugs in prostate cancer.

van der Poel HG. van der Poel HG. Eur Urol. 2004 Jan;45(1):1-17. doi: 10.1016/j.eururo.2003.08.011. Eur Urol. 2004. PMID: 14667509 Review.

8

Mammalian target of rapamycin and 3-phosphatidylinositol 3-kinase pathway inhibition enhances growth inhibition of transforming growth factor-beta1 in prostate cancer cells.

van der Poel HG. van der Poel HG. J Urol. 2004 Oct;172(4 Pt 1):1333-7. doi: 10.1097/01.ju.0000138829.97838.19. J Urol. 2004. PMID: 15371835

9

Urine markers for bladder cancer surveillance: a systematic review.

van Rhijn BW, van der Poel HG, van der Kwast TH. van Rhijn BW, et al. Among authors: van der kwast th, van der poel hg. Eur Urol. 2005 Jun;47(6):736-48. doi: 10.1016/j.eururo.2005.03.014. Epub 2005 Mar 23. Eur Urol. 2005. PMID: 15925067 Review.

10

Upper urinary tract cancer: location is correlated with prognosis.

van der Poel HG, Antonini N, van Tinteren H, Horenblas S. van der Poel HG, et al. Among authors: van tinteren h. Eur Urol. 2005 Sep;48(3):438-44. doi: 10.1016/j.eururo.2005.03.009. Epub 2005 Mar 29. Eur Urol. 2005. PMID: 16115524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

512 results

Search Page